Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.53 No.11

Vol.53 No.11 contents

Presidential Address

Overcoming neurological diseases -breakthrough for new era-

Hidehiro Mizusawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 893|897, 2013

Educational Lecture 2

Immunology for Understanding the Pathogenesis of Multiple Sclerosis

Makoto Matsui, M.D., Ph.D.1)

CLINICA NEUROL, 53: 898|901, 2013

Educational Lecture 2

Conflict of interest of clinical research in Japan

Saburo Sakoda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 902|902, 2013

Educational Lecture 2

Gene mutations; up date

Masanori Nakagawa, M.D.1)

CLINICA NEUROL, 53: 903|906, 2013

Educational Lecture 2

Essential knowledge of Drugs for Neurologists on Pharmacokinetics and Drug Development in Global Aspects to the World

Masahiro Nomoto, M.D., Ph.D.1), Masahiro Nagai, M.D., Ph.D.1), Noriko Nishikawa, M.D., Ph.D.1), Tomoaki Tsujii, M.D.1) and Hirotaka Iwaki, M.D.1)

CLINICA NEUROL, 53: 907|910, 2013

Educational Lecture 3

Update on deep brain stimulation for movement disorders

Atsushi Umemura, M.D., Ph.D.1), Genko Oyama, M.D., Ph.D.2), Yasushi Shimo, M.D., Ph.D.1)2) and Nobutaka Hattori, M.D., Ph.D.2)

CLINICA NEUROL, 53: 911|914, 2013

Educational Lecture 3

Differential diagnosis and common pathology between Alzheimer's disease and vascular dementia

Hidekazu Tomimoto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 915|918, 2013

Educational Lecture 3

Macroscopic findings of brains are helpful in differential diagnosis of neurological disorders

Mari Yoshida, M.D.1)

CLINICA NEUROL, 53: 919|922, 2013

Educational Lecture 3

Problems with countermeasures of health insurance treatment in neurology

Michiya Ito1)

CLINICA NEUROL, 53: 923|925, 2013

Educational Lecture 3

Neurology in Japan before World War II

Akira Takahashi, M.D.1)

CLINICA NEUROL, 53: 926|929, 2013

Educational Lecture 4

Positron Emission Tomography in Neurological Disorders

Kenji Ishii, M.D.1)

CLINICA NEUROL, 53: 930|930, 2013

Educational Lecture 4

Neurorehabilitation for spinocerebellar degeneration

Ichiro Miyai, M.D., Ph.D.1)

CLINICA NEUROL, 53: 931|933, 2013

Educational Lecture 4

Basic knowledge about Kampo for neurologists

Shin-ichi Muramatsu, M.D., Ph.D.1)

CLINICA NEUROL, 53: 934|937, 2013

Educational Lecture 4

Kampo medicines as useful therapeutic agents in clinical practice of neurology: case reports & representative medicines

Kazuyuki Ishida, M.D., Ph.D.1)

CLINICA NEUROL, 53: 938|941, 2013

Hot Topics 2

MicroRNA in neurodegenerative disorders

Gen Sobue, M.D.1)

CLINICA NEUROL, 53: 942|944, 2013

Hot Topics 2

Epilepsy and higher brain dysfunction

Mitsuru Kawamura, M.D.1) and Azusa Sugimoto, M.D.1)

CLINICA NEUROL, 53: 945|945, 2013

Hot Topics 2

Central Institute for the Molecular Pathomechanisms of Epilepsies

Shinichi Hirose, M.D., Ph.D.1)

CLINICA NEUROL, 53: 946|946, 2013

Hot Topics 3

Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia

Yukiko Hayashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 947|950, 2013

Hot Topics 3

How do the interventional neurologists function in the clinical setting?

Mikito Hayakawa, M.D.1)

CLINICA NEUROL, 53: 951|955, 2013

Hot Topics 3

Alzheimer disease: experimental approaches to genetic and environmental risk factors

Takeshi Iwatsubo, M.D.,1), Tadafumi Hashimoto, Ph.D.,1), Tomoko Wakabayashi, Ph.D.,1), Taisuke Tomita, Ph.D.,2) and Yuichi Morohashi, Ph.D.2)Ph.D.,2) and Yuichi Morohashi, Ph.D.2)

CLINICA NEUROL, 53: 956|956, 2013

Hot Topics 3

The world of functional RNA

Hiromi Okada, Ph.D.1) and Yoshihide Hayashizaki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 957|961, 2013

Hot Topics 3

Brain-machine interface (BMI) - application to neurological disorders

Toshiki Yoshimine, M.D.1), Takufumi Yanagisawa, M.D.1), Masayuki Hirata, M.D.1)

CLINICA NEUROL, 53: 962|965, 2013

Hot Topics 4

Role of Neurosurgical Management in Movement Disorders other than Parkinson Disease

Takaomi Taira, M.D., Ph.D.1)

CLINICA NEUROL, 53: 966|968, 2013

Hot Topics 4

Pathogenesis and treatment of brachial plexus neuritis.

Shu-ichi Ikeda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 969|973, 2013

Symposium 1

Non-motor symptoms in premotor phase of Parkinson disease

Kazushi Takahashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 974|976, 2013

Symposium 1

Initial diagnosis of Parkinson's disease -Neuroradiological diagnosis-

Satoshi Orimo, M.D., Ph.D.1)

CLINICA NEUROL, 53: 977|980, 2013

Symposium 1

Transcranial sobography of substantia nigra in patients with Parkinson's disease

Hideto Miwa, M.D.1)

CLINICA NEUROL, 53: 981|982, 2013

Symposium 1

α-synuclein as biomarker

Kenjiro Ono, M.D., Ph. D.1) and Masahito Yamada, M.D., Ph.D.1)

CLINICA NEUROL, 53: 983|985, 2013

Symposium 1

Thrombus formation and its embolic risk in atrial fibrillation

Hideo Mitamura, M.D., Ph.D.1)

CLINICA NEUROL, 53: 986|988, 2013

Symposium 1

Cardioembolic stroke associated with atrial fibrillation

Kazumi Kimura, M.D., Ph.D.1), Shinji Yamashita, M.D., Ph.D.1) and Kensaku Shibazaki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 989|991, 2013

Symposium 1

Evidence of novel oral anticoagulants (NOAC)

Takanari Kitazono, M.D., Ph.D.1)

CLINICA NEUROL, 53: 992|993, 2013

Symposium 1

How to properly use warfarin and new anticoagulants

Shinichiro Uchiyama, M.D., Ph.D.1)

CLINICA NEUROL, 53: 994|996, 2013

Symposium 1

Prevention and treatment of major bleeding during anticoagulation

Masahiro Yasaka, M.D., Ph.D.1) and Yasushi Okada, M.D., Ph.D.1)

CLINICA NEUROL, 53: 997|999, 2013

Symposium 1

The present state of predictive genetic testing for neuromuscular diseases: An overview by a neurologist in a local hospital

Hiroyuki Ohmori, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1000|1002, 2013

Symposium 1

The present condition and problem of presymptomatic genetic testing

Chieko Kukinaka, R.N., LL.M.1)

CLINICA NEUROL, 53: 1003|1005, 2013

Symposium 1

Current status of predictive genetic testing in neurological diseases
-From the stand point of genetic specialist-

Masayuki Yoshida, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1006|1008, 2013

Symposium 1

Cell replacement therapy for Parkinson's disease using iPS cells

Jun Takahashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1009|1012, 2013

Symposium 1

Current status and perspective on regenerative medicine for spinal cord injury using iPS cell

Masaya Nakamura, M.D., Ph.D.1), Yoshiaki Toyama, M.D., Ph.D.1) and Hideyuki Okano, M.D., Ph.D.2)

CLINICA NEUROL, 53: 1013|1015, 2013

Symposium 1

Retinal cell therapy using iPS cells

Masayo Takahashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1016|1016, 2013

Symposium 1

Stem cell therapy for ischemic stroke using iPS cells

Koichi Oki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1017|1019, 2013

Symposium 1

ALS disease modeling and drug screening using patient-specific iPS cells

Naohiro Egawa, M.D., Ph.D.1)2) and Haruhisa Inoue, M.D., Ph.D.1)2)

CLINICA NEUROL, 53: 1020|1022, 2013

Symposium 1

Clinical aspects of corticobasal syndrome

Takayoshi Shimohata, M.D., Ph.D.1) and Masatoyo Nishizawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1023|1025, 2013

Symposium 1

The genetic background of corticobasal syndrome

Hiroshi Doi, M.D., Ph.D.1) and Fumiaki Tanaka, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1026|1028, 2013

Symposium 1

Neuroimaging in corticobasal syndrome

Hitoshi Shinotoh, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1029|1032, 2013

Symposium 1

Differential diagnosis of corticobasal syndrome (CBS) and its biomarkers

Takahiko Tokuda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1033|1035, 2013

Symposium 2

The development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions

Shun Shimohama, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1036|1038, 2013

Symposium 2

Current status and perspectives on the development of AD therapeutics based on amyloid cascade hypothesis

Takeshi Iwatsubo, M.D.1)

CLINICA NEUROL, 53: 1039|1039, 2013

Symposium 2

Present and future of the Tau dementia therapy

Akihiko Takashima, Ph.D.1)

CLINICA NEUROL, 53: 1040|1042, 2013

Symposium 2

Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications

Akihiko Nunomura, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1043|1045, 2013

Symposium 2

Update rehabilitation therapy for Parkinson disease

Akito Hayashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1046|1049, 2013

Symposium 2

Repetitive transcranial magnetic stimulation (rTMS) therapy for Parkinson Disease

Yuichiro Shirota, M.D., Ph. D.1)

CLINICA NEUROL, 53: 1050|1052, 2013

Symposium 2

DBS therapy for Parkinson's disease -Our approach-

Sumito Sato, M.D., Ph.D.1), Yoko Takiyama, M.D., Ph.D.2), Yutaka Ogino, M.D., Ph.D.3), Katsushige Watanabe, M.D., Ph.D.4), Tohru Terao, M.D.5), Chihiro Matsumoto, M.D.1), Satomi Chiken, Ph.D.6), Atsushi Nambu, M.D., Ph.D.6), Kazutoshi Nishiyama, M.D., Ph.D.2), Toshihiro Kumabe, M.D., Ph.D.1) and Kiyotaka Fujii, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1053|1055, 2013

Symposium 2

Problem of alternative medicine in Parkinson's disease

Ken-ichi Fujimoto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1056|1058, 2013

Symposium 2

Autoimmune Encephalitis and its related-disorders

Makoto Yoneda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1059|1062, 2013

Symposium 2

Clinical spectrum of anti-glycine receptor antibody-associated disease

Takahiro Iizuka, M.D.1), Naomi Tominaga, M.D.1) and Juntaro Kaneko, M.D.1)

CLINICA NEUROL, 53: 1063|1066, 2013

Symposium 2

Isaacs's syndrome and associated diseases

Osamu Watanabe, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1067|1070, 2013

Symposium 2

Autoimmune Autonomic Ganglionopathy

Shunya Nakane, M.D.1)2)

CLINICA NEUROL, 53: 1071|1073, 2013

Symposium 2

C9ORF72 in Japanese amyotrophic lateral sclerosis (ALS)

Hiroyuki Tomiyama, M.D., Ph.D1)

CLINICA NEUROL, 53: 1074|1076, 2013

Symposium 2

Molecular pathogenesis of ALS in TDP43 era

Osamu Onodera, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1077|1079, 2013

Symposium 2

Amyotrophic lateral sclerosis (ALS) with the mutations in the fused in sarcoma/translocated in liposarcoma gene

Masashi Aoki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1080|1083, 2013

Symposium 2

Dysfunction of dynactin 1 in motor neuron degeneration

Masahisa Katsuno, M.D., Ph.D.1), Kensuke Ikenaka, M.D., Ph.D.1), Kaori Kawai, Ph.D.1) and Gen Sobue, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1084|1086, 2013

Symposium 2

Cutting-edge MRI techniques for studying neurological diseases focusing on spinocerebellar degeneration

Hirohisa Watanabe, M.D.1), Joe Senda, M.D.1), Mizuki Ito, M.D.1), Naoki Atsuta, M.D.1), Kazuhiro Haram, M.D.1), Hazuki Watanabe1), Ryoichi Nakamura, M.D.1), Takashi Tsuboi, M.D.1), Mari Yoshida, M.D.2), Shinji Naganawa, M.D.3) and Gen Sobue, M.D.1)

CLINICA NEUROL, 53: 1087|1090, 2013

Symposium 2

Principles of voxel-based morphometry and availability of integrated software BAAD

Akihiko Shiino, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1091|1093, 2013

Symposium 2

Cutting-edge of advanced MRI for demyelinating diseases

Masafumi Harada, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1094|1096, 2013

Symposium 2

MRI in Epilepsy and Migraine

Toshihiko Aso, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1097|1099, 2013

Symposium 2

In-vivo analysis for human brain maturation using MRI

Yuji Suzuki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1100|1103, 2013

Symposium 2

α-dystroglycanopathy

Tatsushi Toda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1104|1104, 2013

Symposium 2

Myofibrillar myopaathy

Yukiko Hayashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1105|1108, 2013

Symposium 2

Myotonic dystrophy

Shoichi Ishiura, Ph.D.1), Kosuke Oana, M.S.1) and Michinori Koebis, M.S.1)

CLINICA NEUROL, 53: 1109|1111, 2013

Symposium 2

New congenital muscular dystrophy due to CHKB mutations

Ichizo Nishino, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1112|1113, 2013

Symposium 2

Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies

Jun Shimizu, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1114|1116, 2013

Symposium 2

Immortalized adult rodent Schwann cells as useful tools for the study of peripheral nerve regeneration

Kazunori Sango, M.D., Ph.D.1) and Kazuhiko Watabe, M.D., Ph.D.2)

CLINICA NEUROL, 53: 1117|1119, 2013

Symposium 2

Blood-nerve barrier and peripheral nerve regeneration

Takashi Kanda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1120|1122, 2013

Symposium 2

New horizon of treatments for peripheral nerve disorders

Hitoshi Hirata, M.D., Ph.D.1), Shigeru Kurimoto, M.D., Ph.D.1) and Shuichi Kato, M.D.1)

CLINICA NEUROL, 53: 1123|1123, 2013

Symposium 2

Regenerative medicine of central and peripheral nervous system

Hideyuki Okano, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1124|1124, 2013

Symposium 2

The recent pathophysiology of cluster headache (trigeminal autonomic cephalalgias; TACs)

Tomokazu Shimazu, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1125|1127, 2013

Symposium 2

Clinical profile of cluster headaches in Japan

Noboru Imai, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1128|1130, 2013

Symposium 2

New treatments for cluster headache

Toshihiko Shimizu, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1131|1133, 2013

Symposium 2

Therapeuetic aspects of cluster headache in the practical clinical site

Kiyoshi Owada, M.D.1)

CLINICA NEUROL, 53: 1134|1135, 2013

Symposium 2

International Accreditation of Medical School Towards Quality Assurance of Medical Education

Toshimasa Yoshioka, M.D., Ph.D.1) and Nobuo Nara, M.D., Ph.D.2)

CLINICA NEUROL, 53: 1136|1138, 2013

Symposium 2

An update on postgraduate clinical training

Masahiro Tanabe, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1139|1141, 2013

Symposium 2

Renovation of medical specialty education system in Japan (Current status and future perspectives)

Akira Muraoka, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1142|1144, 2013

Symposium 2

Graduate medical education for neurology in Japan

Masatoyo Nishizawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1145|1146, 2013

Symposium 2

The current status and problems in neurology education at graduate schools in Japan

Jun-ichi Kira, M.D, Ph.D.1)

CLINICA NEUROL, 53: 1147|1147, 2013

Symposium 3

Earthquake and Neurologists -Role of Neurologist as a primary care physician-

CLINICA NEUROL, 53: 1148|1148, 2013

Symposium 3

The management of patients receiving home respiratory care with tracheostomy and positive-pressure ventilation

Masashi Aoki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1149|1151, 2013

Symposium 3

Action proposals to Japanese Neurological Society from Fukushima Medical University: based on our three years' experiences

Yoshikazu Ugawa, M.D.1)

CLINICA NEUROL, 53: 1152|1154, 2013

Symposium 3

IT Network establishment for neuropatients

Koji Abe, M.D., P.h.D.1), Shinichiro Uchiyama, M.D.2), Etsuro Matsubara, M.D, Ph.D.3),Shin-ichi Muramatsu, M.D.4), Naoki Atsuta, M.D.5), Kazuo Kitagawa, M.D., Ph.D.6), Yasuyuki Iguchi, M.D., Ph.D.7), Hiroaki Ooboshi, M.D., Ph.D.8), Ryuji Kaji, M.D.9) and Yasuo Terao, M.D., Ph.D.10)

CLINICA NEUROL, 53: 1155|1158, 2013

Symposium 3

Pathophysiology of brain injury and targets of treatment in acute ischemic stroke

Kortaro Tanaka, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1159|1162, 2013

Symposium 3

Intravenous rt-PA therapy: Current status and extending therapeutic time window in Japan

Kazuo Minematsu, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1163|1165, 2013

Symposium 3

Current status of endovascular therapy for acute ischemic stroke

Hiroshi Yamagami, M.D., Ph.D.1) and Nobuyuki Sakai, M.D., D.M.Sc.2)

CLINICA NEUROL, 53: 1166|1168, 2013

Symposium 3

Brain protection against cerebral ischemia

Kazuo Kitagawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1169|1171, 2013

Symposium 3

Antiplatelet and anticoagulation therapy in acute cerebral infarction

Yoshiaki Itoh, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1172|1174, 2013

Symposium 3

Cell therapy for stroke

Osamu Honmou, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1175|1176, 2013

Symposium 3

Rehabilitation for patients with cerebral infarction after transplantation of autologous human mesenchymal stem cells

Sumio Ishiai, M.D.1)

CLINICA NEUROL, 53: 1177|1179, 2013

Symposium 3

Olfactory mucosa autograft for chronic complete spinal cord injury

Koichi Iwatsuki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1180|1182, 2013

Symposium 3

The basic strategy of rehabilitation for regeneration of spinal cord nerve

Fumihiro Tajima, M.D., Ph.D.1) and Takeshi Nakamura, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1183|1183, 2013

Symposium 3

Rapid identification of meningitis due to bacterial pathogens

Kimiko Ubukata, Ph.D.1)

CLINICA NEUROL, 53: 1184|1186, 2013

Symposium 3

Current advancement of the PCR-based molecular diagnosis for tuberculous meningitis

Teruyuki Takahashi, M.D.1), Masato Tamura, M.D.1)2), Toshiaki Takasu, M.D.1)2) and Satoshi Kamei, M.D.2)

CLINICA NEUROL, 53: 1187|1190, 2013

Symposium 3

Genetic diagnosis against fungal cerebromeningitis

Hideaki Ohno, M.D., Ph.D.1) and Yoshitsugu Miyazaki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1191|1193, 2013

Symposium 3

The diagnosis of toxoplasmic encephalitis by polymerase chain reaction

Takashi Asai, Ph.D.1)

CLINICA NEUROL, 53: 1194|1195, 2013

Symposium 3

History of Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P)

Hiroshi Takashima, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1196|1198, 2013

Symposium 3

Pathomechanisms of motor neuron death by mutant TFG

Toshitaka Kawarai, M.D.1), Mitsuya Morita, M.D.2), Ryoma Morigaki, M.D.3), Koji Fujita, M.D.1), Hiroyuki Nodera, M.D.1), Yuishin Izumi, M.D.1), Satoshi Goto, M.D.3), Imaharu Nakano, M.D.4) and Ryuji Kaji, M.D.1)

CLINICA NEUROL, 53: 1199|1199, 2013

Symposium 3

Neuropathology of proximal-dominant hereditary motor and sensory neuropathy (HMSN-P)

Mari Yoshida, M.D.1)

CLINICA NEUROL, 53: 1200|1202, 2013

Symposium 3

Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is caused by a mutation in TFG

Hiroyuki Ishiura, M.D. Ph.D.1) and Shoji Tsuji, M.D, Ph.D.1)

CLINICA NEUROL, 53: 1203|1205, 2013

Symposium 3

Muscle ultrasonography: A new diagnostic tool for the diagnosis of ALS

Sonoko Misawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1206|1207, 2013

Symposium 3

Ultrasonographic diagnosis of demyelinating neuropathy

Takamichi Sugimoto, M.D.1) Kazuhide Ochi, M.D., Ph.D.1) and Masayasu Matsumoto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1208|1211, 2013

Symposium 3

Ultrasonography of muscle disease

Yuka Terasawa, M.D., Ph.D.1), Naoko Takamatsu, M.T.1) and Ryuji Kaji, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1212|1214, 2013

Symposium 3

Nerve ultrasound is useful for the diagnosis of neuromuscular diseases.

Yu-ichi Noto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1215|1216, 2013

Symposium 3

Ultrasonography for the management of carpal tunnel syndrome

Kenichi Nakamichi, M.D.1)

CLINICA NEUROL, 53: 1217|1219, 2013

Symposium 4

Pathophysiology of migraine chronification

Mamoru Shibata, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1220|1222, 2013

Symposium 4

Current status of migraine chronification in Japan

Hisanori Kowa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1223|1224, 2013

Symposium 4

Societal impact of migraine chronification

Hisaka Igarashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1225|1227, 2013

Symposium 4

Management of chronic migraine in Japan

Yuka Watanabe, M.D., Ph.D.1), Ryotaro Takashima, M.D., Ph.D.1), Hisatake Iwanami, M.D., Ph.D.1), Shiho Suzuki, M.D., Ph.D.1), Hisaka Igarashi, M.D., Ph.D.2) and Koichi Hirata, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1228|1230, 2013

Symposium 4

Localization in neuropsychology

Kyoko Suzuki, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1231|1233, 2013

Symposium 4

Neural correlates of memory

Toshikatsu Fujii, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1234|1236, 2013

Symposium 4

Aphasia-a new as well as old problem

Kazuo Hadano, M.D.1)

CLINICA NEUROL, 53: 1237|1239, 2013

Symposium 4

Neuropsychology of consciousness

Katsuhiko Takeda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1240|1242, 2013

Symposium 4

Review of basic knowledge, surveillance and infectious control of prion disease

Nobuo Sanjo, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1243|1245, 2013

Symposium 4

Clinical manifestations and epidemiology of prion diseases in Japan.

Tsuyoshi Hamaguchi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1246|1248, 2013

Symposium 4

Neuroimaging in the differential diagnosis of prion disease

Koji Fujita, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1249|1251, 2013

Symposium 4

CSF analysis of patients with prion disease by biomarkers and Real-time qucking-induced conversion (RT-QUIC) method

Katsuya Satoh, M.D.1)

CLINICA NEUROL, 53: 1252|1254, 2013

Symposium 4

Treatment for prion disease: recent progress

Yoshio Tsuboi, M.D.1)

CLINICA NEUROL, 53: 1255|1257, 2013

Symposium 4

Treatment of spasticity with botulinum toxin

Ai Miyashiro, M.D.1)

CLINICA NEUROL, 53: 1258|1260, 2013

Symposium 4

Spasticity must be treated by botulinum toxin with rehabilitaiton

Yoshihisa Masakado, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1261|1263, 2013

Symposium 4

Repetitive transcranial magnetic stimulation and Rehabilitation

Masahiro Abo, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1264|1266, 2013

Symposium 4

Repetitive facilitative exercise: Recent evidence and development for combination therapy

Megumi Shimodozono, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1267|1269, 2013

Symposium 4

Clinical application of prism adaptation for patients with unilateral spatial neglect

Hisaaki Ota, Ph.D.1)

CLINICA NEUROL, 53: 1270|1272, 2013

Symposium 4

Overview of involuntary movements

Yoshikazu Ugawa, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1273|1274, 2013

Symposium 4

Pathophysiology in dystonia: functional anatomy of basal ganglia

Satoshi Goto, M.D.1) and Ryuji Kaji, M.D.2)

CLINICA NEUROL, 53: 1275|1275, 2013

Symposium 4

Pathophysiology of tremor rhythm

Ritsuko Hanajima, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1276|1278, 2013

Symposium 4

Pathophysiology of cortical myoclonus

Tatsuya Mima, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1279|1280, 2013

Symposium 4

Future medical care for intractable diseases, general view

Mieko Ogino, M.D., Ph.D. MMA.1)

CLINICA NEUROL, 53: 1281|1281, 2013

Symposium 4

The prospective program for intractable diseases

Naoko Yamamoto, M.D., M.P.H., Ph.D.1)2)

CLINICA NEUROL, 53: 1282|1282, 2013

Symposium 4

Global strategy for rare and intractable diseases

Tomoko Kawashima Kodama, M.D., M.P.H., Ph.D.1)

CLINICA NEUROL, 53: 1283|1286, 2013

Symposium 4

Medical Treatment of NANBYO from patients' perspective

Tateo Ito1)

CLINICA NEUROL, 53: 1287|1289, 2013

Symposium 4

Comments on the issue and future strategy of policy toward the rare intractable diseases from a standpoint of a neurology specialist

Shigeki Kuzuhara, M.D.1)

CLINICA NEUROL, 53: 1290|1290, 2013

Symposium 4

Management of infectious diseases at home care settings

Kentaro Iwata, M.D.1)

CLINICA NEUROL, 53: 1291|1291, 2013

Symposium 4

Nutritional management in amyotrophic lateral sclerosis: palliative and end-of-life care

Toshio Shimizu, M.D.1)

CLINICA NEUROL, 53: 1292|1294, 2013

Symposium 4

Home care medicine for terminally ill patients

Shohei Kawagoe, M.D.1)

CLINICA NEUROL, 53: 1295|1295, 2013

Symposium 4

To aim at better home medical care

Michiaki Nagura, M.D.1)

CLINICA NEUROL, 53: 1296|1298, 2013

Symposium 4

Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis

Yuriko Nagane, M.D.1)

CLINICA NEUROL, 53: 1299|1302, 2013

Symposium 4

Treatment of pure ocular myasthenia: a proposal from Japan MG registry 2012

Shigeaki Suzuki, M.D.1)

CLINICA NEUROL, 53: 1303|1305, 2013

Symposium 4

Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis

Tomihiro Imai, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1306|1308, 2013

Symposium 4

Calcineurin inhibitors and IVIg in the treatment of myasthenia gravis

Shunya Nakane, M.D.1)2)

CLINICA NEUROL, 53: 1309|1311, 2013

Symposium 4

A proposal for rituximab treatment in patients with myasthenia gravis

Shingo Konno, M.D.1)

CLINICA NEUROL, 53: 1312|1314, 2013

Symposium 4

Prognostic factors in Guillain-Barré syndrome

Kenichi Kaida, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1315|1318, 2013

Symposium 4

Fisher syndrome and Bickerstaff brainstem encephalitis

Satoshi Kuwabara, M.D.1)

CLINICA NEUROL, 53: 1319|1321, 2013

Symposium 4

A nationwide survey of patients with Bickerstaff brainstem encephalitis: Diversity of underlying mechanism

Michiaki Koga, M.D.1)

CLINICA NEUROL, 53: 1322|1324, 2013

Symposium 4

CLINICA NEUROL, 53: 1325|1325, 2013

Symposium 4

Autoimmune autonomic ganglionopathy and acute autonomic and sensory neuropathy

Haruki Koike, M.D., Ph.D.1) and Gen Sobue, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1326|1329, 2013

Symposium 4

Overview -exploring molecular basis of sporadic neurologic disorders-

Shoji Tsuji, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1330|1332, 2013

Symposium 4

Chromosomal structural variation -An approach for multiple system atrophy

Ichiro Yabe, M.D., Ph.D.1) and Hidenao Sasaki, M.D, Ph.D.1)

CLINICA NEUROL, 53: 1333|1335, 2013

Symposium 4

Toward identification of susceptible genes for sporadic neurodegenerative disease

Jun Mitsui, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1336|1338, 2013

Symposium 4

Epigenome: what we learned from Rett syndrome, a neurological disease caused by mutation of a methyl-CpG binding protein

Takeo Kubota, M.D.1)

CLINICA NEUROL, 53: 1339|1341, 2013

Symposium 4

Clinical practice guidelines of the Societas Neurologica Japonica

Takeo Nakayama, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1342|1342, 2013

Symposium 4

JSN Treatment Guideline for Parkinson's Disease: its editorial policy and problems to be addressed

Ryosuke Takahashi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1343|1345, 2013

Symposium 4

Treatment & management guidelines 2011 for Parkinson disease

Atsushi Takeda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1346|1347, 2013

Symposium 4

Clinical experiences of the Japanese treatment guideline on Parkinson's disease

Tetsuya Maeda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1348|1350, 2013

Symposium 4

Practice of the Parkinson's disease in the neurology clinic and the role of Guideline

Yoshihisa Tatsuoka, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1351|1351, 2013

Symposium 4

Practical guideline of Parkinson's disease in Japan: evaluation and mission of future

Mitsutoshi Yamamoto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1352|1353, 2013

Symposium 4

Present status of Japanese neurologists from the questionnaire survey
-to support women doctor's career advancement-

Hikoaki Fukaura, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1354|1357, 2013

Symposium 4

Efforts of gender equality at Kinki University School of Medicine

Katsuichi Miyamoto, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1358|1360, 2013

Symposium 4

Career support systems for female physicians in Tokyo Women's Medical University

Yoriko Kawakami, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1361|1362, 2013

Symposium 4

Advanced approach for gender-equal career enhancement

Yumi Narushima1)

CLINICA NEUROL, 53: 1363|1363, 2013

Symposium 4

Contribution of emergency medicine by neurologists in the western countries: residency training is the key

Hiroyuki Nodera, M.D.1)

CLINICA NEUROL, 53: 1364|1365, 2013

Symposium 4

Immediate stroke life support: Training for neuroresuscitation team in ER

Hiroshi Okudera, M.D., Ph.D.1) and Megumi Takahashi, M.D., Ph.D.2)

CLINICA NEUROL, 53: 1366|1368, 2013

Symposium 4

Significant role of neurologists at ER practice

Hideki Nomura, M.D., Ph.D.1), Chizuko Oishi, M.D.2) and Takeaki Matsuda, M.D., Ph.D.3)

CLINICA NEUROL, 53: 1369|1369, 2013

Symposium 4

Contribution of neurologists to emergent stroke medicine in Japan

Kazunori Toyoda, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1370|1372, 2013

Symposium 4

What ER physicians expects from neurologist

Tomoki Nakamori, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1373|1375, 2013

Symposium 4

The cardiac reserve in Parkinson's disease and exercise therapy

Masaaki Hirayama, M.D.1)2), Tomohiko Nakamura, M.D.2) and Gen Sobue, M.D.2)

CLINICA NEUROL, 53: 1376|1378, 2013

Symposium 4

Impaired exercise-induced blood pressure control in patients with Parkinson's disease and related disorders

Kazushi Deguchi, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1379|1381, 2013

Symposium 4

Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease

Hirokazu Doi, Ph.D.1), Ryuji Sakakibara, M.D. Ph.D.2), Masahiko Kishi, M.D. Ph.D.2), Yohei Tsuyuzaki, M.D.2), Fuyuki Tateno, M.D.2) and Shigekazu Hirai1)

CLINICA NEUROL, 53: 1382|1385, 2013

Symposium 4

Cognitive function and blood pressure regulation in Lewy body diseases

Masato Asahina, M.D, Ph.D.1)

CLINICA NEUROL, 53: 1386|1388, 2013

Symposium 4

Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB

Ryuji Sakakibara, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1389|1392, 2013

Symposium 4

Clinical feature of ALS with communication disturbance; the possibility to communication in TLS

Masahiro Nagao, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1393|1395, 2013

Symposium 4

Predictors the progression of communication impairment in ALS Tracheostomy Ventilator users

Yuki Nakayama, R.N., Ph.D.1), Toshio Shimizu, M.D.2), Kentaro Hayashi, M.D.2), Yoko Mochizuki, M.D., Ph.D.3)4), Masahiro Nagao, M.D., Ph.D.2) and Kiyomitsu Oyanagi, M.D, Ph.D.5)

CLINICA NEUROL, 53: 1396|1398, 2013

Symposium 4

Amyotrophic lateral sclerosis in totally locked-in state

Kiyomitsu Oyanagi, M.D., Ph.D.1), Yoko Mochizuki, M.D., Ph.D.2)3), Yuki Nakayama, R.N., Ph.D.4), Kentaro Hayashi, M.D.5), Toshio Shimizu, M.D.5), Masahiro Nagao, M.D.5), Tomoyo Hashimoto, M.D., Ph.D.1)6), Mineo Yamazaki, M.D., Ph.D.7), Shiro Matsubara, M.D., Ph.D.5) and Takashi Komori, M.D., Ph.D.2)

CLINICA NEUROL, 53: 1399|1401, 2013

Symposium 4

Development of a cognitive BMI "neurocommunicator" as a communication aid of patients with severe motor deficits

Ryohei P. Hasegawa, Ph.D.1)

CLINICA NEUROL, 53: 1402|1404, 2013

Symposium 4

Communication with ALS patients: Neurosurgical approach

Toshiki Yoshimine, M.D., Ph.D.1), Takufumi Yanagisawa, M.D., Ph.D.1), Jin-ichi Sawada, M.D., Ph.D.3), Takanori Hazama, M.D., Ph.D.3), Hideki Mochizuki, M.D., Ph.D.2) and Masayuki Hirata, M.D., Ph.D.1)

CLINICA NEUROL, 53: 1405|1407, 2013